Selank is a synthetic heptapeptide analogue of tuftsin, an endogenous immune-related tetrapeptide, extended with a Pro-Gly-Pro stabilizing tripeptide also found in Semax.

What does published research study Selank for?

The literature — rat gene-expression studies, human cell-culture assays, in-vitro enzyme work, and a small number of published clinical trials — has investigated Selank in relation to GABAergic-system gene expression, enkephalin-degrading enzyme inhibition, immune-marker changes, and learning performance in rodent behavioral models. These are studied mechanisms and animal/cell-model observations, not established human effects.

Is there human clinical evidence for Selank?

Yes, though it is more limited in scale than for some other research peptides — a published Russian trial examined Selank's efficacy and proposed mechanisms in patients with generalized anxiety disorder and neurasthenia, and a separate published study examined Selank's immunomodulatory effects in patients with anxiety-asthenic disorders. These studies are older, smaller, and concentrated in Russian-language clinical literature rather than large multi-site pharmaceutical trials. Selank is not an FDA-approved drug in the United States.

How does Selank compare to Semax?

The two share a stabilizing Pro-Gly-Pro extension and a Russian neuropeptide research lineage, but they are derived from different parent peptides — tuftsin for Selank, an ACTH fragment for Semax — and the published literature studies largely different pathways for each (GABAergic/enkephalin for Selank; neurotrophin/melanocortin for Semax).

What is the proposed mechanism behind Selank's studied effects?

Gene-expression research reports that Selank produces changes in GABAergic-neurotransmission genes correlated with those produced by GABA itself, interpreted as allosteric modulation of the GABA-A receptor complex rather than direct binding. A separate mechanistic thread reports that Selank inhibits enkephalin-degrading enzymes in vitro, and a synthesis review has proposed the enkephalin system as a central node connecting several of Selank's studied effects.

How is research-grade Selank supplied?

Typically as a lyophilized (freeze-dried) powder for reconstitution in a laboratory setting, accompanied by a Certificate of Analysis confirming HPLC-verified purity.

Materials described here are for laboratory research only and are not for human consumption. Nothing here is medical advice.

September 27, 2026 · Obsessed Living Research Team

Selank Research FAQ

These answers are written for a research audience and deliberately avoid any health, dosing, or outcome claims. Selank is supplied for laboratory research use only and is not for human consumption.

The Obsessed Living Research Team summarizes peer-reviewed peptide research for educational, research-use reference. Content is not medical advice.

References

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells
Semax and Selank Inhibit the Enkephalin-Degrading Enzymes of Human Serum
Physiological Effects of Selank and Its Fragments
Immunomodulatory Effects of Selank in Patients with Anxiety-Asthenic Disorders
Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia
The Optimizing Action of the Synthetic Peptide Selank on a Conditioned Active Avoidance Reflex in Rats

Compliance & Disclaimer

This product is supplied strictly for research purposes only. It is not intended for human or animal consumption and is not intended for therapeutic, dietary, cosmetic, diagnostic, or veterinary use.

Statements on this page have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Human/animal consumption prohibited. Laboratory/in-vitro experimental use only.